Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
132
-
Total 13F shares, excl. options
-
36.2M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$537M
-
Value change
-
+$29.4M
-
Put/Call ratio
-
2.26
-
Number of buys
-
70
-
Number of sells
-
-60
-
Price
-
$14.84
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q2 2024
159 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q2 2024.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.2M shares
of 38M outstanding shares and own 95.25% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.73M shares), RA CAPITAL MANAGEMENT, L.P. (3.52M shares), EcoR1 Capital, LLC (3.25M shares), Boxer Capital, LLC (2.95M shares), MPM ASSET MANAGEMENT LLC (2.74M shares), VANGUARD GROUP INC (2.05M shares), Vestal Point Capital, LP (1.75M shares), MPM BIOIMPACT LLC (1.75M shares), 683 Capital Management, LLC (1.12M shares), and MORGAN STANLEY (1.09M shares).
This table shows the top 132 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.